These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24244658)

  • 1. Limited promiscuity of HLA-DRB1 presented peptides derived of blood coagulation factor VIII.
    van Haren SD; Wroblewska A; Herczenik E; Kaijen PH; Ruminska A; ten Brinke A; Meijer AB; Voorberg J
    PLoS One; 2013; 8(11):e80239. PubMed ID: 24244658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.
    van Haren SD; Herczenik E; ten Brinke A; Mertens K; Voorberg J; Meijer AB
    Mol Cell Proteomics; 2011 Jun; 10(6):M110.002246. PubMed ID: 21467215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.
    Steinitz KN; van Helden PM; Binder B; Wraith DC; Unterthurner S; Hermann C; Schuster M; Ahmad RU; Weiller M; Lubich C; de la Rosa M; Schwarz HP; Reipert BM
    Blood; 2012 Apr; 119(17):4073-82. PubMed ID: 22394599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells.
    Peyron I; Hartholt RB; Pedró-Cos L; van Alphen F; Brinke AT; Lardy N; Meijer AB; Voorberg J
    Haematologica; 2018 Jan; 103(1):172-178. PubMed ID: 29025906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hunting down factor VIII in the immunopeptidome.
    Hartholt RB; Peyron I; Voorberg J
    Cell Immunol; 2016 Mar; 301():59-64. PubMed ID: 26610639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII.
    Sorvillo N; Hartholt RB; Bloem E; Sedek M; ten Brinke A; van der Zwaan C; van Alphen FP; Meijer AB; Voorberg J
    Haematologica; 2016 Mar; 101(3):309-18. PubMed ID: 26635035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A.
    Jacquemin M; Vantomme V; Buhot C; Lavend'homme R; Burny W; Demotte N; Chaux P; Peerlinck K; Vermylen J; Maillere B; van der Bruggen P; Saint-Remy JM
    Blood; 2003 Feb; 101(4):1351-8. PubMed ID: 12393451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of Naturally Processed Peptides Reveals Convergent Presentation of Autoantigenic Topoisomerase I Epitopes in Scleroderma.
    Tiniakou E; Fava A; McMahan ZH; Guhr T; O'Meally RN; Shah AA; Wigley FM; Cole RN; Boin F; Darrah E
    Arthritis Rheumatol; 2020 Aug; 72(8):1375-1384. PubMed ID: 32162841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential HLA-DRB1*11-dependent presentation of CUB2-derived peptides by ADAMTS13-pulsed dendritic cells.
    Sorvillo N; van Haren SD; Kaijen PH; ten Brinke A; Fijnheer R; Meijer AB; Voorberg J
    Blood; 2013 Apr; 121(17):3502-10. PubMed ID: 23372163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products.
    Jankowski W; Park Y; McGill J; Maraskovsky E; Hofmann M; Diego VP; Luu BW; Howard TE; Kellerman R; Key NS; Sauna ZE
    Blood Adv; 2019 May; 3(9):1429-1440. PubMed ID: 31053570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII.
    Jones TD; Phillips WJ; Smith BJ; Bamford CA; Nayee PD; Baglin TP; Gaston JS; Baker MP
    J Thromb Haemost; 2005 May; 3(5):991-1000. PubMed ID: 15869596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell and T-cell epitopes in anti-factor VIII immune responses.
    Pratt KP; Thompson AR
    Clin Rev Allergy Immunol; 2009 Oct; 37(2):80-95. PubMed ID: 19184559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4(+) T lymphocytes.
    Yasukawa M; Ohminami H; Kojima K; Hato T; Hasegawa A; Takahashi T; Hirai H; Fujita S
    Blood; 2001 Sep; 98(5):1498-505. PubMed ID: 11520800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating the microenvironment during FVIII uptake influences the nature of FVIII-peptides presented by antigen-presenting cells.
    Lubich C; Steinitz KN; Hoelbl B; Prenninger T; van Helden PM; Weiller M; Reipert BM
    Front Immunol; 2022; 13():975680. PubMed ID: 36389737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors.
    Dasgupta S; Repessé Y; Bayry J; Navarrete AM; Wootla B; Delignat S; Irinopoulou T; Kamaté C; Saint-Remy JM; Jacquemin M; Lenting PJ; Borel-Derlon A; Kaveri SV; Lacroix-Desmazes S
    Blood; 2007 Jan; 109(2):610-2. PubMed ID: 16985172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein.
    Bozzacco L; Yu H; Dengjel J; Trumpfheller C; Zebroski HA; Zhang N; Küttner V; Ueberheide BM; Deng H; Chait BT; Steinman RM; Mojsov S; Fenyö D
    PLoS One; 2012; 7(7):e41897. PubMed ID: 22860026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
    Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM
    J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of naïve human T cells.
    Mishra S; Losikoff PT; Self AA; Terry F; Ardito MT; Tassone R; Martin WD; De Groot AS; Gregory SH
    Vaccine; 2014 May; 32(26):3285-92. PubMed ID: 24721533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.